Skip to main content
SpringerLink
Log in

Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Abnormal phosphatase and tensin analog (PTEN) gene expression has been noted in neoplasms. The PTEN protein cleaves phosphate groups from cellular growth kinases inhibiting tumor propagation. A downstream target ofPTEN is AKT, a serine-threonine kinase that when activated inhibits apoptosis. We sought to determine whether PTEN overexpression in mesotheliooma cells would engender hypophosphorylation of AKT and apoptosis.

Methods

Human malignant mesothelioma cell lines REN and I–45 were transfected with adenoviral vectors AdPTEN and AdBgal (marker gene) at various multiplicities of infection (MOI). Cell viability was measured using a colorimetric assay and apoptosis was assessed by morphology and subG1 fluorescence-activated cell sorter (FACS) analysis. PTEN protein and AKT phophorylation were evaluated by Western blot, and AKT kinase activity was evaluated by functional assay.

Results

Increased cellular killing was noted with AdPTEN gene transfer. The ratio of cell killing with AdPTEN to AdBgal widened with increasing MOI and was statistically signficant at all MOI. Cells demonstrated apoptosis by morphologic and subG1 FACS analyses. Cells overexpressing PTEN demonstrated decreased phosphorylated (active) AKT and AKT kinase activity compared with controls.

Conclusions

Overexpression of PTEN engenders apoptosis in mesothelioma by AKT hypophosphorylation. The forced overexpression of PTEN may prove useful clinically in this treatment-resistant neoplasm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Chapter © 2013

References

  1. Carbone M, Rizzo P, Pass H. Simian virus 40: the link with human malignant mesothelioma is well established.Anticancer Res 2000; 20:875–8

    PubMed  CAS  Google Scholar 

  2. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.J. Thorac Cardiovasc Surg 1999;117:54–65.

    Article  PubMed  CAS  Google Scholar 

  3. Ong T, Vogelzang NJ. Chemotherapy in malignant mesothelioma: a review.J Clin Oncol 1996;14:1007–17.

    PubMed  CAS  Google Scholar 

  4. Smythe WR, Hwang HC, Elshami AA, et al. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.Ann Surg 1995;222:78–86.

    Article  PubMed  CAS  Google Scholar 

  5. Moskal TL, Doughtery TJ, Urschel JD, et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year followup.Ann Thorac Surg 1998;66:11128–33.

    Article  Google Scholar 

  6. Christmas TI, Manning LS, Garlepp MJ, Musk AW, Robinson BW. Effect of interferon-alpha 2a on malignant mesothelioma.J. Interferon Res 1993;13:9–12.

    PubMed  CAS  Google Scholar 

  7. Eggermont AMM, Goey SH, Slingerland R, et al. Clinical and immunological evaluation of intrapleural interleukin-1 in malignant pleural mesothelioma: a phase II study (abstract).Proc Am Assoc Cancer Res 1991;32:206–9.

    Google Scholar 

  8. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic.Br J Cancer 1999;79:666–72.

    Article  PubMed  CAS  Google Scholar 

  9. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus of transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an, effective in vitro drug sensitization system.Cancer Res 1994;54:2055–9.

    PubMed  CAS  Google Scholar 

  10. Dahia PLM. PTEN, a unique tumor suppressor gene.Endocr Relat Cancer 2000;7:115–29.

    Article  PubMed  CAS  Google Scholar 

  11. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.Nat Genet 1997;16:64–7.

    Article  PubMed  CAS  Google Scholar 

  12. Besson A, Robbins S, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.Eur J Biochem 1999;263:605–11.

    Article  PubMed  CAS  Google Scholar 

  13. Bonneau D, Longy M. Mutations of the human PTEN gene.Hum Mutat 2000;16:109–11.

    Article  PubMed  CAS  Google Scholar 

  14. Tamura M, Gu J, Tran H, Yamada K. PTEN gene and integrin signaling in cancer.J Natl Cancer Inst 1999;91:1820–8.

    Article  PubMed  CAS  Google Scholar 

  15. Sterman DH, Treat J, Litzky LA, et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with low malignancy results of a phase I clinical trial in malignant mesothelioma.Hum Gene Ther 1998;9:1083–92.

    PubMed  CAS  Google Scholar 

  16. Narasimhan SR, Yang L, Gerwin BI, Broaddus VC. Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of bcl-2 and bax.Am J Physiol 1998;275:L165–71.

    PubMed  CAS  Google Scholar 

  17. Broaddus VC, Yang L, Scavo LM, Ernst JD, Boylan AM. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species.J Clin Invest 1996;98:2050–9.

    Article  PubMed  CAS  Google Scholar 

  18. Marklund L, Henriksson, R, Grankvist K. Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+, K+, 2Cl(−)-contransport blocker bumetanide.Life Sci 2000;66:PL319–24.

    Article  PubMed  CAS  Google Scholar 

  19. Nasreen N, Mohammed KA, Dowling PA, Ward MJ, Galffy G, Antony VB. Talc induces apoptosis in human malignant mesothelioma cells in vitro.Am J Respir Crit Care Med 2000;161:595–600.

    PubMed  CAS  Google Scholar 

  20. Rubins JB, Greatens T, Kratzke RA, Tan AT, Polunovsky VA, Bitterman P. Lovastatin induces apoptosis in malignant mesothelioma cells.Am J Respir Crit Care Med 1998;175:1616–22.

    Google Scholar 

  21. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine kinase gene mutated in brain, breast and prostate cancer.Science 1997; 275:1943–7.

    Article  PubMed  CAS  Google Scholar 

  22. Marsh DJ, Coulon V, Lunetta KL, et al. Mutation spectrum and genotype-phenotype analysis in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.Hum Mol Genet 1998;7:507–15.

    Article  PubMed  CAS  Google Scholar 

  23. Forgacs E, Biesterveld EJ, Sekido Y, et al. Mutation analysis of the PTEN/MMAC gene in lung cancer.Oncogene 1998;17:1557–65.

    Article  PubMed  CAS  Google Scholar 

  24. Yokomizo A, Tindall DJ, Drabkin H, et al. PTEN/MMAC mutations identified in small cell but not in non-small, cell lung cancers.Oncogene 1998;17:475–9.

    Article  PubMed  CAS  Google Scholar 

  25. Teng DH, Hu R, Lin H, et al. MMAC/PTEN mutations in primary tumor specimens and tumor cell lines.Cancer Res 1997;57:5221–5.

    PubMed  CAS  Google Scholar 

  26. Li D, Sun H. PTEN/MMAC/TEP1 suppresses the tumorigenicity and induces G1 arrest in human glioblastoma cells.Proc Natl Acad Sci U S A 1998;95:15406–11.

    Article  PubMed  CAS  Google Scholar 

  27. Cheng Y, Ng HK, Zhang SF, et al. Genetic alterations in pediatric high-grade astrocytomas.Hum Pathol 1999;11:1284–90.

    Article  Google Scholar 

  28. Zhou XP, Li YJ, Hoang-Xuan K. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.Int J Cancer 1999;84:150–4.

    Article  PubMed  CAS  Google Scholar 

  29. Calleja V, Stoll V, Vassaux G Downward J, Lemoine N. Gene therapy for cancer using dominant negative mutants of the RAS/PI-3? AKT signalling molecules (abstract No. 603). Presented at the Fourth Annual Meeting of The American Society For Gene Therapy, Seattle, WA, May 30–June 3, 2001.

Download references

Author information

Authors and Affiliations

  1. Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 109, 77030, Houston, TX

    Imran Mohiuddin MD, Xiaobo Cao MD, Mustafa K. Ozvaran MD, Lou Zumstein PhD, Sunil Chada PhD & W. Roy Smythe MD

Authors
  1. Imran Mohiuddin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaobo Cao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa K. Ozvaran MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lou Zumstein PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sunil Chada PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Roy Smythe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Roy Smythe MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohiuddin, I., Cao, X., Ozvaran, M.K. et al. Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation. Annals of Surgical Oncology 9, 310–316 (2002). https://doi.org/10.1007/BF02573071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573071

Key Words

Search

Navigation